Clinical Trial Update: Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease [Phase 2]

View source ↗

Summary

AbbVie is conducting a Phase 2 clinical trial to evaluate targeted therapies for adults with moderate to severe Crohn's disease; the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 2 | Status: RECRUITING